Stay updated on Foster® pMDI vs Symbicort® Turbohaler in COPD Patient Clinical Trial
Sign up to get notified when there's something new on the Foster® pMDI vs Symbicort® Turbohaler in COPD Patient Clinical Trial page.

Latest updates to the Foster® pMDI vs Symbicort® Turbohaler in COPD Patient Clinical Trial page
- ChecktodayChange DetectedThe footer revision label was updated from v3.7.2 to v3.8.0 while the study record remains unavailable behind a 403 Forbidden page.SummaryDifference0.2%

- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedAn NIH website transition notice appears above the 403 error page, and the footer revision label changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check28 days agoChange DetectedThe ClinicalTrials.gov footer revision changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check35 days agoChange DetectedThe page previously showing a 403 error was replaced, removing the 403 content and Home link, and the standard study details layout now appears to load.SummaryDifference0.5%

- Check42 days agoChange DetectedThe NCT03888131 page now shows a 403 Forbidden error, replacing the usual study details and linked documents. This indicates access to the study record is blocked at the URL.SummaryDifference19%

- Check49 days agoChange DetectedRevision tag updated from v3.6.6 to v3.7.0 on the study details page, indicating a newer build or update to the page.SummaryDifference0.0%

Stay in the know with updates to Foster® pMDI vs Symbicort® Turbohaler in COPD Patient Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Foster® pMDI vs Symbicort® Turbohaler in COPD Patient Clinical Trial page.